Is OCD Genetic? What the Research on Heredity Actually Shows

If OCD runs in your family, or if you have OCD and are thinking about what that means for your children, you have probably wondered how hereditary it really is. The answer is more nuanced than “yes it’s genetic” or “no, it’s not” — and recent research has made it significantly more specific.

This page covers what the science actually shows about OCD genetics: how much of OCD is heritable, what we know about which genes and systems are involved, and what family history means clinically for risk and early intervention.

What This Page Covers

• How researchers measure heritability and what the numbers mean
• What twin and family studies show about OCD genetics
• The 2025 genome-wide association study and what it found
• Which biological systems are implicated
• What genetic risk means practically for families
• What treatment looks like regardless of genetic profile

What “Heritable” Actually Means

Heritability estimates tell you how much of the variation in who develops a condition is attributable to genetic differences between people. A heritability of 50% doesn’t mean 50% of your OCD is caused by genes. It means that across the population, roughly half of the differences in who gets OCD versus who doesn’t can be explained by genetic variation.

This is an important distinction because it means genetics is a substantial but not exclusive contributor. The other roughly half comes from what researchers call non-shared environmental factors: experiences, exposures, and circumstances that aren’t shared between family members.

Notably, the shared family environment, including household dynamics, parenting style, and shared experiences, has little contribution to OCD risk. OCD in families reflects genetic transmission, not family environment. This matters enormously for reducing stigma: parents of children with OCD did not cause the condition by how they raised them.

What Twin Studies Show

Twin studies are the most powerful tool for estimating heritability because they directly compare identical twins (who share nearly 100% of their DNA) with fraternal twins (who share about 50%).

If OCD were purely genetic, identical twins would always share the diagnosis. They don’t. When one identical twin has OCD, the other has it about 50–65% of the time. This tells us that genetics is necessary but not sufficient, which is consistent with a heritability estimate around 48–50%.

Fraternal twins, by contrast, share OCD at much lower rates. Large twin studies consistently report monozygotic twin correlations of 0.52–0.43 compared to dizygotic twin correlations of 0.27–0.20, in children and adult samples respectively. The pattern is consistent across studies and supports a substantial additive genetic contribution.

One of the most statistically robust twin studies, by Monzani et al., reported an overall heritability of 48% for OCD. A 2023 systematic review and meta-analysis of 19 family studies, 29 twin studies, and 6 population-based studies confirmed a phenotypic heritability of approximately 50%.

Early-onset OCD shows even stronger heritability. Family studies consistently find that the familial risk is especially pronounced among relatives of children and adolescent probands — meaning OCD that begins in childhood has a particularly strong genetic component.

What Family Studies Show

Family studies measure how often OCD appears in relatives of people who have it, compared to relatives of people who don’t.

The findings are consistent: first-degree relatives of people with OCD are four to five times more likely to develop OCD than relatives of people without OCD. Population-based studies using Danish national registries confirmed this, reporting a sibling relative recurrence risk of 4.9 and a parent-offspring relative recurrence risk of 6.3.

Over 15 family studies of OCD support the familial transmission of OCD. One of the earliest reports in the English literature, based on 50 cases at the Maudsley Hospital in London, found that 37% of parents and 21% of siblings of affected individuals also had the disorder. Subsequent studies with more rigorous methodology have confirmed the familial pattern.

These numbers don’t mean that everyone with a family history will develop OCD. They mean the risk is meaningfully elevated, which is clinically useful information for monitoring symptoms and intervening early if they appear.

The 2025 GWAS: The Largest OCD Genetics Study Ever Conducted

In May 2025, researchers published results from the largest genome-wide association study of OCD ever conducted, analyzing DNA from more than 53,660 people with OCD and over 2,044,417 controls. The study identified 30 independent genome-wide significant loci associated with OCD.

The study also identified 249 potential effector genes, with 25 classified as the most likely causal candidates, including WDR6, DALRD3, and CTNND1, along with multiple genes in the major histocompatibility complex (MHC) region.

OCD genetic risk was associated with excitatory neurons in the hippocampus and the cortex, along with D1 and D2 type dopamine receptor-containing medium spiny neurons. This is consistent with what prior research had suggested about the role of cortico-striato-thalamo-cortical (CSTC) circuits in OCD.

The researchers estimated that approximately 11,500 causal variants account for 90% of OCD’s SNP-based heritability, confirming that OCD is a complex polygenic condition. This means there is no single “OCD gene” to look for.

The Biology: Which Systems Are Involved

Decades of research across genetics, pharmacology, and neuroimaging have pointed consistently to specific systems and circuits in OCD.

The CSTC Circuit: The cortico-striato-thalamo-cortical loop connects the prefrontal cortex (involved in decision-making and error detection) to the striatum and thalamus. In OCD, this circuit is believed to function with hyperactivity, leading to a breakdown in the system that filters unwanted thoughts and behaviors. The circuit keeps generating alarm signals that the person cannot turn off, which manifests as obsessions and the compulsive attempts to neutralize them.

Serotonin: The effectiveness of SSRIs in OCD, which require higher doses and longer trials than for depression, has long pointed to serotonin dysregulation as a central mechanism. Variations in genes affecting serotonin transport, such as the SERT gene, have been linked to OCD.

Dopamine: Dopamine plays a role in motivation and reward, and the COMT gene, which affects dopamine metabolism, is one example of a variant associated with elevated dopamine levels in some people with OCD.

Genetic Overlap With Other Conditions

OCD doesn’t exist in genetic isolation. OCD genetic risk was shared with 65 of 112 additional phenotypes examined in the 2025 GWAS, including all other psychiatric disorders studied.

The genetic overlap between OCD and Tourette syndrome is well-established. Family studies have reported evidence of shared familial transmission between OCD, Tourette syndrome, and ADHD. This explains why OCD frequently co-occurs with tic disorders and why both conditions appear in the same families.

What This Means for Families

Knowing that OCD has a significant genetic component changes what you can do, not as a way to predict with certainty who will develop it, but as a way to recognize it earlier when it does appear.

Children of people with OCD have a meaningfully elevated risk, particularly if the parent’s OCD began in childhood. Knowing this:

• Helps you watch for early signs of intrusive thoughts, ritualistic behavior, or avoidance in young family members
• Creates a context for taking symptoms seriously and seeking evaluation earlier rather than later
• Removes the guilt of wondering whether the condition was caused by something you did

OCD that is recognized and treated early has better outcomes than OCD identified years into its course. Effective treatments exist, including exposure and response prevention (ERP), the gold standard behavioral therapy for OCD, and SSRI medications at appropriate doses and treatment durations.

About SiggyMD

OCD is outside SiggyMD’s current clinical scope. If you’re experiencing OCD symptoms, a clinician specializing in OCD and ERP therapy is the appropriate primary resource.

For the anxiety and depression that often co-occur with OCD, SiggyMD provides clinician-supervised care with daily check-ins that build a longitudinal record of what’s working. The intake is free, anonymous, and requires no account, name, or email.

For related reading, see our guide on types of OCD.

Start your anonymous intake with SiggyMD to discuss anxiety and depression that may co-occur with OCD.

What Members Are Saying

MK

M.K., 41

OCD, Co-occurring Depression

“My mother had OCD. My grandmother had something that, looking back, was almost certainly OCD. When I was diagnosed, it wasn’t a shock — but I still felt like something must have gone wrong. Learning about the genetics helped me understand it as a medical condition I was predisposed to, not a reflection of something I’d failed at. That shift mattered for how I approached treatment.”

R.N., 27

OCD in Childhood, Adult Recurrence

“My OCD started around age 8. It improved in my teens and I thought I was done with it. It came back in a different form in my mid-20s. My psychiatrist explained that early-onset OCD is typically more genetically based and that recurrence is common, especially under stress. That information was uncomfortable and also useful.”

Member stories reflect real experiences. Names and identifying details have been changed to protect privacy. Results vary. You can begin anonymous intake without an account, name, email, or payment.

If you are in crisis or experiencing thoughts of self-harm, call or text 988. If you are in immediate danger, call 911.

Sources

1. Blanco-Vieira T, Radua J, et al. The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysis. Translational Psychiatry. 2023;13:230.

2. Mathews CA, Grice DE. Genetics of Obsessive-Compulsive Disorder and Related Disorders. Psychiatric Clinics of North America. 2014;37(3):319-335.

3. Pauls DL. Genetics of OCD. Dialogues in Clinical Neuroscience. 2010;12(2):149-163.

4. Levey DF, et al. Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. Nature Genetics. 2025.

5. Monzani B, Rijsdijk F, Harris J, Mataix-Cols D. The structure of genetic and environmental risk factors for dimensional representations of DSM-5 obsessive-compulsive spectrum disorders. JAMA Psychiatry. 2014;71(2):182-189.

6. Zouki JJ, et al. Genetic underpinnings of obsessive-compulsive disorder with and without tics. American Journal of Medical Genetics Part B. 2025.

7. National Institute of Mental Health. Obsessive-Compulsive Disorder (OCD). NIMH. Reviewed 2023.

8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). APA Publishing, 2022.